PT2437762T - Lágrimas artificiais e usos terapêuticos - Google Patents

Lágrimas artificiais e usos terapêuticos

Info

Publication number
PT2437762T
PT2437762T PT107246316T PT10724631T PT2437762T PT 2437762 T PT2437762 T PT 2437762T PT 107246316 T PT107246316 T PT 107246316T PT 10724631 T PT10724631 T PT 10724631T PT 2437762 T PT2437762 T PT 2437762T
Authority
PT
Portugal
Prior art keywords
therapeutic uses
artificial tears
tears
artificial
therapeutic
Prior art date
Application number
PT107246316T
Other languages
English (en)
Inventor
V Gore Anuradha
S Jordan Robert
Krock Kevin
Pujara Chetan
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42312750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2437762(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of PT2437762T publication Critical patent/PT2437762T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
PT107246316T 2009-06-05 2010-06-03 Lágrimas artificiais e usos terapêuticos PT2437762T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18433909P 2009-06-05 2009-06-05

Publications (1)

Publication Number Publication Date
PT2437762T true PT2437762T (pt) 2017-11-14

Family

ID=42312750

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107246316T PT2437762T (pt) 2009-06-05 2010-06-03 Lágrimas artificiais e usos terapêuticos

Country Status (24)

Country Link
US (6) US8496976B2 (pt)
EP (1) EP2437762B1 (pt)
KR (1) KR101778316B1 (pt)
CN (2) CN104906170A (pt)
AU (1) AU2010256652B2 (pt)
BR (1) BRPI1011710B8 (pt)
CA (1) CA2764802A1 (pt)
DK (1) DK2437762T3 (pt)
ES (1) ES2646338T3 (pt)
HK (1) HK1214943A1 (pt)
HR (1) HRP20171691T1 (pt)
HU (1) HUE034213T2 (pt)
IL (1) IL216800A (pt)
LT (1) LT2437762T (pt)
MX (2) MX358504B (pt)
MY (1) MY172185A (pt)
NO (1) NO2437762T3 (pt)
NZ (1) NZ596932A (pt)
PL (1) PL2437762T3 (pt)
PT (1) PT2437762T (pt)
RU (1) RU2589837C2 (pt)
SI (1) SI2437762T1 (pt)
WO (1) WO2010141648A2 (pt)
ZA (1) ZA201108979B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8496976B2 (en) 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
JP6142419B2 (ja) * 2011-12-07 2017-06-07 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 塩感受性エマルジョン系を用いたヒト涙液膜への効率的脂質送達
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
TWI659737B (zh) 2012-03-30 2019-05-21 布萊恩霍頓視力協會 用於降低眼部不適的方法及組成物
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions
HUE048702T2 (hu) 2014-08-20 2020-07-28 Silk Tech Ltd Fibroinból származó fehérjekészítmény
KR102487299B1 (ko) * 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
US10286035B2 (en) 2015-10-14 2019-05-14 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
CA3020342A1 (en) 2016-04-08 2017-11-23 Cornell University A method to enhance wound healing using silk-derived protein
DK3266446T3 (en) 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride
EP3496662A4 (en) 2016-08-12 2019-10-30 Silk Technologies Ltd. PROTEIN DERIVED FROM SILK FOR THE TREATMENT OF INFLAMMATION
CN109689161A (zh) * 2016-08-19 2019-04-26 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
KR20200037230A (ko) * 2017-06-30 2020-04-08 제니비젼 인크. 모발 성장용 제제
US11622982B2 (en) 2017-08-18 2023-04-11 Akrivista Llc Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CA3106898A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
KR20210038636A (ko) 2018-07-27 2021-04-07 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 눈 치료용 조성물 및 방법
EP3829614A2 (en) 2018-07-27 2021-06-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
KR20210009947A (ko) 2019-07-18 2021-01-27 윤영선 산소가 도입된 점안제, 및 그 제조방법
EP3824895A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824877A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104814A (en) * 1980-01-25 1981-08-20 Kunihiro Okanoe Preparation of eye drop
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
KR920003601B1 (ko) 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
CH679210A5 (pt) * 1988-10-26 1992-01-15 Sandoz Ag
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
AU1172097A (en) 1995-12-27 1997-07-28 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition containing trehalose
US5981607A (en) 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
GB0012597D0 (en) 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
US7027446B2 (en) 2001-07-18 2006-04-11 P-Cube Ltd. Method and apparatus for set intersection rule matching
JP4284491B2 (ja) 2002-07-16 2009-06-24 豊和工業株式会社 ピストン外形の加工データ生成装置
UY28126A1 (es) * 2002-12-24 2004-06-30 Alcon Inc Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular
CN1777411B (zh) * 2003-02-24 2013-01-02 药品生产公司 经粘膜药物递送系统
US20060251685A1 (en) 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
NZ552481A (en) 2004-07-01 2008-12-24 Schepens Eye Res Compositions and methods for treating eye disorders and conditions
WO2006022291A1 (ja) * 2004-08-27 2006-03-02 Senju Pharmaceutical Co, .Ltd. ドライアイ治療用点眼液
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CN100562340C (zh) * 2005-06-17 2009-11-25 中国科学院上海药物研究所 一种微乳型人工泪液
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008027341A2 (en) * 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
CA2679448A1 (en) * 2007-02-28 2008-09-04 Aciex, Inc. Methods and compositions for normalizing meibomian gland secretions
CN101554369B (zh) * 2008-05-12 2012-07-25 陈亚玲 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法
UA36915U (uk) * 2008-05-28 2008-11-10 Львівський Національний Медичний Університет Ім. Данила Галицького Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
US8496976B2 (en) 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses

Also Published As

Publication number Publication date
BRPI1011710A2 (pt) 2016-03-22
EP2437762B1 (en) 2017-08-09
NZ596932A (en) 2014-04-30
HUE034213T2 (en) 2018-01-29
WO2010141648A2 (en) 2010-12-09
ES2646338T3 (es) 2017-12-13
IL216800A0 (en) 2012-02-29
MY172185A (en) 2019-11-15
BRPI1011710B8 (pt) 2021-05-25
DK2437762T3 (da) 2017-11-20
HK1214943A1 (zh) 2016-08-12
MX2011013007A (es) 2012-02-28
KR20120046151A (ko) 2012-05-09
ZA201108979B (en) 2012-08-29
AU2010256652B2 (en) 2015-11-26
US11045515B2 (en) 2021-06-29
NO2437762T3 (pt) 2018-01-06
US20130295206A1 (en) 2013-11-07
CA2764802A1 (en) 2010-12-09
KR101778316B1 (ko) 2017-09-13
US20120201910A1 (en) 2012-08-09
US20180264063A1 (en) 2018-09-20
US8496976B2 (en) 2013-07-30
BRPI1011710A8 (pt) 2019-11-05
RU2589837C2 (ru) 2016-07-10
LT2437762T (lt) 2017-11-27
PL2437762T3 (pl) 2018-01-31
HRP20171691T1 (hr) 2017-12-15
BRPI1011710B1 (pt) 2021-01-26
US8679554B2 (en) 2014-03-25
US9821020B2 (en) 2017-11-21
EP2437762A2 (en) 2012-04-11
US20240108677A1 (en) 2024-04-04
MX358504B (es) 2018-08-21
RU2011151468A (ru) 2013-07-20
SI2437762T1 (en) 2018-02-28
WO2010141648A3 (en) 2011-03-10
US20140141106A1 (en) 2014-05-22
CN104906170A (zh) 2015-09-16
IL216800A (en) 2017-03-30
US20220008496A1 (en) 2022-01-13
AU2010256652A1 (en) 2012-01-12
CN102458430A (zh) 2012-05-16

Similar Documents

Publication Publication Date Title
HK1214943A1 (zh) 人工淚液及治療用途
IL220261A0 (en) Intraocular devices and associated methods
IL214797A0 (en) Lacrimal implants and related methods
GB2472856B (en) IL1-RAP modulators and uses thereof
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
IL218212A0 (en) Therapeutic methods and compositions
IL213974A0 (en) Isoxazole-isoxazole and isoxazole-isothiazole derivatives
SI2483292T1 (sl) Variantni polipeptidi lovd in njihove uporabe
EP2268281A4 (en) THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
EP2339668A4 (en) BATTERY AND BATTERY UNIT
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
EP2269612A4 (en) EYE DROP PREPARATION AND ITS USE
PT2563806E (pt) Leucolectinas humanas e suas utilizações
GB0908868D0 (en) Depsipeptide and their therapeutic use
EP2427129A4 (en) DEVICES AND METHODS FOR MODIFYING FABRICS
GB0912744D0 (en) Methods and uses
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB0809329D0 (en) Depsipeptides and their therapeutic use
GB0903145D0 (en) Medicaments uses and methods
GB0910620D0 (en) Agents and uses thereof
GB0913955D0 (en) Lactams and their therapeutic use
GB0920904D0 (en) Uses and methods
GB0906043D0 (en) Nalmefene compositions and their therapeutic use
GB0906046D0 (en) Nalmefene compositions and their therapeutic use